Takeda Pharmaceutical
TAK
#398
Rank
NZ$96.48 B
Marketcap
NZ$30.54
Share price
-1.55%
Change (1 day)
18.16%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : NZ$85.03 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are NZ$85.03 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31NZ$86.01 B-0.49%
2024-03-31NZ$86.44 B-5.05%
2023-03-31NZ$91.04 B2.56%
2022-03-31NZ$88.77 B-11.24%
2021-03-31NZ$100.01 B-20.94%
2020-03-31NZ$126.49 B11.32%
2019-03-31NZ$113.62 B318.42%
2018-03-31NZ$27.15 B-11.62%
2017-03-31NZ$30.72 B31.95%
2016-03-31NZ$23.28 B-0.43%
2015-03-31NZ$23.38 B3.26%
2014-03-31NZ$22.65 B4.35%
2013-03-31NZ$21.70 B2.65%
2012-03-31NZ$21.14 B106.36%
2011-03-31NZ$10.24 B3.35%
2010-03-31NZ$9.91 B-21.49%
2009-03-31NZ$12.62 B97.13%
2008-03-31NZ$6.40 B-11.72%
2007-03-31NZ$7.25 B-25.45%
2006-03-31NZ$9.73 B37.01%
2005-03-31NZ$7.10 B-11.32%
2004-03-31NZ$8.00 B6.26%
2003-03-31NZ$7.53 B-18.76%
2002-03-31NZ$9.27 B-6.24%
2001-03-31NZ$9.89 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$201.55 B 137.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$110.31 B 29.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$198.07 B 132.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$137.92 B 62.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$113.09 B 33.01%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$132.98 B 56.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$104.97 B 23.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
NZ$1.85 B-97.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$3.57 B-95.80%๐Ÿ‡ฎ๐Ÿ‡ณ India